InvestSMART

Cyclopharm Limited (ASX: CYC) - Announcements

Current share price for CYC : $0.450 0.025 (5.88%)+

ASX company news and announcements for Cyclopharm Limited (CYC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cyclopharm Limited (CYC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cyclopharm Limited (CYC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cyclopharm Limited (CYC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$57 Trading Halt 21 Jan 2021 8:46AM $2.940 $0.450 fallen by 84.69%
$57 USFDA Approval Progress for Technegas and Business Update 14 Jan 2021 1:44PM $2.400 $0.450 fallen by 81.25%
$57 Bell Potter Healthcare Conference 26 Nov 2020 9:34AM $2.200 $0.450 fallen by 79.55%
$57 Change of Director's Interest Notice TM 22 Oct 2020 11:45AM $2.000 $0.450 fallen by 77.50%
$57 Change of Director's Interest Notice 1 Oct 2020 5:17PM $2.380 $0.450 fallen by 81.09%
$57 Change of Director's Interest Notice 29 Sep 2020 2:31PM $2.260 $0.450 fallen by 80.09%
$57 Cyclopharm Investor Presentation 23 Sep 2020 8:27AM $2.350 $0.450 fallen by 80.85%
$57 Technegas USA Trial Successfully Meets Primary Endpoint 15 Sep 2020 1:15PM $1.400 $0.450 fallen by 67.86%
$57 CYC Partners With McMasters University In COVID-19 Research 9 Sep 2020 9:42AM $1.365 $0.450 fallen by 67.03%
$57 Half Year 2020 Financial Results 25 Aug 2020 4:02PM $1.300 $0.450 fallen by 65.38%
$57 Half Yearly Report and Accounts 25 Aug 2020 3:57PM $1.300 $0.450 fallen by 65.38%
$57 Dividend/Distribution - CYC 25 Aug 2020 3:53PM $1.300 $0.450 fallen by 65.38%
$57 Change of Director's Interest Notice 27 Jul 2020 1:42PM $1.500 $0.450 fallen by 70%
$57 Appendix 2A 27 Jul 2020 1:42PM $1.500 $0.450 fallen by 70%
$57 Results of Meeting 9 Jul 2020 1:52PM $1.515 $0.450 fallen by 70.30%
$57 Managing Director's Address to Shareholders 9 Jul 2020 11:19AM $1.495 $0.450 fallen by 69.90%
$57 CYC 2020 AGM Presentation 9 Jul 2020 11:16AM $1.495 $0.450 fallen by 69.90%
$57 Chairman's Address to Shareholders 9 Jul 2020 11:15AM $1.495 $0.450 fallen by 69.90%
$57 CYC 1H2020 Business Update 7 Jul 2020 8:18AM $1.495 $0.450 fallen by 69.90%
$57 Notice of Annual General Meeting/Proxy Form 5 Jun 2020 8:20AM $1.510 $0.450 fallen by 70.20%
$57 Technegas Approved in Russia - Clarification 29 May 2020 5:22PM $1.540 $0.450 fallen by 70.78%
$57 USFDA Approval to File Received for Technegas 27 May 2020 8:32AM $1.420 $0.450 fallen by 68.31%
$57 Technegas Approved in Russia 26 May 2020 9:52AM $1.375 $0.450 fallen by 67.27%
$57 Final share buy-back notice - Appendix 3F 21 May 2020 3:24PM $1.350 $0.450 fallen by 66.67%
$57 Form 484 cancellation of Long Term Incentive Plan shares 6 May 2020 11:51AM $1.155 $0.450 fallen by 61.04%

326 - 350 of 617 results

Page 14 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.